Orange Book product · Generic (ANDA)
LANREOTIDE ACETATE
LANREOTIDE ACETATE
Generic (ANDA)ANDA 217193TE ABRX INVAGEN PHARMS
At a glance
May 21, 2024
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 21, 2024
2 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
LANREOTIDE ACETATE
Strength
EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
Dosage form
SOLUTION
Route
SUBCUTANEOUS
TE code
AB
Application
ANDA 217193
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LANREOTIDE ACETATE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
